Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × Pharmacogenomic Variants × Clear all

Sponsor

Conditions

Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Glioma 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Ependymoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Adrenal Cortex Neoplasms 1

Interventions

Cyclophosphamide 13 Etoposide 9 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Doxorubicin 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Whole-Body Irradiation 6 Vincristine 6 Melphalan 6 fludarabine 5 Rituximab 5 Mycophenolic Acid 5 Granulocyte Colony-Stimulating Factor 4 Gemcitabine 4 Busulfan 4 10-propargyl-10-deazaaminopterin 4 pembrolizumab 3 etoposide phosphate 3 Tacrolimus 3 Lenalidomide 3 Filgrastim 3 Cytarabine 3 Carmustine 3 Antilymphocyte Serum 3 thymoglobulin 2 prednylidene 2 deltacortene 2 carmustine, poliferprosan 20 drug combination 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡